Screening, Brief Intervention, and Referral to Treatment for Offenders (SBIRT)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to determine whether SBIRT is an effective intervention with inmates and to estimate the costs of providing SBIRT to this population.
| Condition | Intervention |
|---|---|
|
Substance Use HIV Infections |
Behavioral: SBIRT Behavioral: Control Group |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Screening, Brief Intervention, and Referral to Treatment for Offenders |
- A reduction in the use of drugs and alcohol [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- Participation in treatment [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- Rearrest and incarceration [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- Quality of life [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- A reduction in HIV risk behaviors [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- The cost benefit of SBIRT for offenders [ Time Frame: 12 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 800 |
| Study Start Date: | April 2012 |
| Estimated Study Completion Date: | March 2016 |
| Estimated Primary Completion Date: | March 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: SBIRT Group
Baseline demographic data will be collected. Subjects will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Experimental subjects, in addition to their risk score and informational materials, will also receive a brief intervention and a referral to treatment appropriate to their risk score from trained health educators. The health educators will be provided by Homeless Health Care, Los Angeles.
|
Behavioral: SBIRT
Screening, brief intervention, and referral to treatment.
|
|
Active Comparator: Control Group
Baseline demographic data will be collected. Subjects will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
|
Behavioral: Control Group
Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
|
Detailed Description:
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based practice that has been found to be effective in reducing alcohol and illicit drug use, mainly among persons recruited in medical centers, primary care offices, emergency rooms, and colleges and universities. But SBIRT has the potential to be applicable to other populations that have, or that are at risk for, substance use problems. In particular, offenders have high prevalence of drug and alcohol use at varying levels of severity and often do not receive adequate intervention, either because of limited availability of programs, low motivation, or lack of awareness of the consequences of their substance use.
The scientific aims of the study are:
- Assess the effectiveness of SBIRT with offenders in terms of participation in brief intervention (if so indicated) and enrollment in treatment (if so indicated).
- Assess the effectiveness of SBIRT with offenders in terms of drug use, criminal activity, and criminal justice involvement at 12 months following baseline.
- Determine whether there are differences in acceptability, participation, and outcomes between men and women.
- Determine the cost of providing the SBIRT intervention with this population.
The clinical aims of the study are:
- To complement the use of SBIRT within Los Angeles County's substance abuse treatment system.
- To expand prevention and treatment options for offenders with substance abuse problems.
To our knowledge, this would be the first rigorous test of SBIRT with an offender population.
We will recruit inmates at two Los Angeles County Sheriff jail facilities, one for men and one for women (25% of total sample), and randomly assign them to the treatment (SBIRT) group (N =400) or to the control (no intervention) group (N = 400). Baseline demographic data will be collected. Subjects in both groups will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Control subjects will receive only their risk score and informational materials regarding the health risks of substance use. Experimental subjects, in addition to their risk score and informational materials, will also receive a brief intervention and a referral to treatment appropriate to their risk score from trained health educators. The health educators will be provided by Homeless Health Care, Los Angeles. Twelve months after study admission, all study participants will be contacted for a follow-up interview. We will obtain records-based data on arrests and jail incarceration over the follow-up period from the Sheriff's Department and the California Department of Justice. We will also collect subject participation in publicly-funded treatment from the Substance Abuse Prevention and Control Division of the Los Angeles County Department of Health.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
The sample for the study will be drawn from an offender population who are within 2-3 weeks of their release from MCJ or CRDF in Los Angeles County. In addition, subjects must be:
- At least 18 years of age
- English or Spanish speaking
- Not subject to extended jail or prison sentence
- Able to provide informed consent to participate in the study
Exclusion Criteria:
Study exclusion criteria:
- Inability to provide informed consent to study participation because of cognitive impairment.
- Inability to communicate in either English or Spanish
- Refusal to complete Locator form for follow-up.
Contacts and Locations| Contact: Michael Prendergast, Ph.D | (310) 267-5503 |
| United States, California | |
| University of California | Recruiting |
| Los Angeles, California, United States, 90025 | |
| Principal Investigator: | Michael Prendergast, Ph.D | UCLA Integrated Substance Abuse Programs |
| Study Director: | Jerry Cartier, M.A. | UCLA Integrated Substance Abuse Programs |
More Information
No publications provided
| Responsible Party: | Michael Prendergast, Principal Investigator, University of California, Los Angeles |
| ClinicalTrials.gov Identifier: | NCT01683643 History of Changes |
| Other Study ID Numbers: | R01DA031879 |
| Study First Received: | September 5, 2012 |
| Last Updated: | March 8, 2013 |
| Health Authority: | United States: National Institute on Drug Abuse |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on May 16, 2013